Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| KIT | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 1.11E5 | Evidence |
|
||||
| KIT | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 9.66E4 | Evidence |
|
||||
| KIT | CRKL | CRKL: Crk-like protein | 8.90E4 | Evidence |
O
|
||||
| KIT | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 4.90E4 | Evidence |
|
||||
| KIT | NCK2 | NCK2: Cytoplasmic protein NCK2 | 3.76E4 | Evidence | |||||
| KIT | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 2.92E4 | Evidence | |||||
| KIT | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 2.57E4 | Evidence | |||||
| KIT | GRAP | GRAP: GRB2-related adapter protein | 1.40E4 | Evidence |
O
|
||||
| KIT | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 1.07E4 | Evidence | |||||
| KIT | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 1.07E4 | Evidence | |||||
| KIT | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 6.36E3 | Evidence | |||||
| KIT | JUP | JUP, CTNNG, DP3: Junction plakoglobin | 3.62E3 | Evidence | |||||
| KIT | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 477.0 | Evidence | |||||
| KIT | LNK | SH2B3, LNK: SH2B adapter protein 3 | 224.0 | Evidence |
|
||||
| KIT | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 224.0 | Evidence | |||||
| KIT | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 206.0 | Evidence | |||||
| KIT | SYK | SYK: Tyrosine-protein kinase SYK | 206.0 | Evidence | |||||
| KIT | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 206.0 | Evidence |
|
||||
| KIT | STAT3 | 200.0 | Evidence | ||||||
| KIT | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 185.0 | Evidence |
O
|
||||
| KIT | JAK1 | 167.0 | Evidence | ||||||
| KIT | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 167.0 | Evidence | |||||
| KIT | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 167.0 | Evidence |
|
||||
| KIT | VAV1 | VAV1, VAV: Proto-oncogene vav | 149.0 | Evidence | |||||
| KIT | CSK | CSK: Tyrosine-protein kinase CSK | 149.0 | Evidence | |||||
| KIT | BMX | N/A | 149.0 | Evidence | |||||
| KIT | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 147.0 | Evidence |
|
||||
| KIT | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 147.0 | Evidence | |||||
| KIT | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 147.0 | Evidence | |||||
| KIT | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 147.0 | Evidence | |||||
| KIT | GRB10 | N/A | 141.0 | Evidence |
|
||||
| KIT | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 135.0 | Evidence |
|
||||
| KIT | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 132.0 | Evidence | |||||
| KIT | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 132.0 | Evidence | |||||
| KIT | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 132.0 | Evidence |
O
|
||||
| KIT | APS | SH2B2, APS: SH2B adapter protein 2 | 132.0 | Evidence |
|
||||
| KIT | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 125.0 | Evidence |
|
||||
| KIT | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 121.0 | Evidence |
|
||||
| KIT | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 119.0 | Evidence |
O
|
||||
| KIT | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 110.0 | Evidence |
|
||||
| KIT | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 92.10 | Evidence | |||||
| KIT | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 89.20 | Evidence |
|
||||
| KIT | CRK | CRK: Proto-oncogene C-crk | 85.60 | Evidence |
|
||||
| KIT | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 82.50 | Evidence |
|
||||
| KIT | LYN | LYN: Tyrosine-protein kinase Lyn | 80.00 | Evidence |
|
||||
| KIT | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 72.70 | Evidence |
|
||||
| KIT | HCK | N/A | 52.50 | Evidence |
|
||||
| KIT | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 39.10 | Evidence | |||||
| KIT | ADAM15 | ADAM15, MDC15: ADAM 15 precursor | 37.80 | Evidence | |||||
| KIT | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 37.80 | Evidence | |||||
| KIT | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 37.80 | Evidence | |||||
| KIT | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 37.80 | Evidence | |||||
| KIT | TRPV4 | TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb | 37.80 | Evidence | |||||
| KIT | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 37.80 | Evidence | |||||
| KIT | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 37.40 | Evidence | |||||
| KIT | NCAM1 | NCAM1, NCAM: Neural cell adhesion molecule 1, 140 kDa isoform precursor | 34.80 | Evidence | |||||
| KIT | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 34.80 | Evidence |
|
||||
| KIT | EPOR | EPOR: Erythropoietin receptor precursor | 34.80 | Evidence |
|
||||
| KIT | EPHA8 | EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor | 33.90 | Evidence | |||||
| KIT | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 33.90 | Evidence | |||||
| KIT | CNTN1 | CNTN1: Contactin-1 precursor | 33.90 | Evidence | |||||
| KIT | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 33.90 | Evidence | |||||
| KIT | ADAM33 | ADAM33, UNQ873/PRO1891: ADAM 33 precursor | 33.90 | Evidence | |||||
| KIT | PTPRF | PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor | 33.90 | Evidence | |||||
| KIT | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 32.70 | Evidence |
O
|
||||
| KIT | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 32.70 | Evidence | |||||
| KIT | FRS3 | FRS3: Fibroblast growth factor receptor substrate 3 | 30.30 | Evidence | |||||
| KIT | ERBB4 | ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor | 28.20 | Evidence | |||||
| KIT | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 28.20 | Evidence | |||||
| KIT | THY1 | THY1: Thy-1 membrane glycoprotein precursor | 28.20 | Evidence | |||||
| KIT | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 28.20 | Evidence | |||||
| KIT | FIGF | FIGF, VEGFD: Vascular endothelial growth factor D precursor | 26.70 | Evidence | |||||
| KIT | EPS15 | EPS15, AF1P: Epidermal growth factor receptor substrate 15 | 25.70 | Evidence | |||||
| KIT | INSR | INSR: Insulin receptor precursor | 25.3 | Evidence | |||||
| KIT | EPHA4 | EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor | 25.3 | Evidence | |||||
| KIT | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 25.3 | Evidence | |||||
| KIT | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 25.20 | Evidence | |||||
| KIT | FLT3 | FLT3, STK1: FL cytokine receptor precursor | 25.00 | Evidence | |||||
| KIT | NEDD9 | NEDD9, CASL: Enhancer of filamentation 1 | 24.90 | Evidence | |||||
| KIT | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 24.90 | Evidence | |||||
| KIT | GHR | GHR: Growth hormone receptor precursor | 24.80 | Evidence | |||||
| KIT | MAG | MAG, GMA: Myelin-associated glycoprotein precursor | 24.80 | Evidence | |||||
| KIT | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 24.80 | Evidence | |||||
| KIT | CD79A | CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain | 24.80 | Evidence | |||||
| KIT | CD4 | CD4: T-cell surface glycoprotein CD4 precursor | 24.80 | Evidence | |||||
| KIT | ITGB4 | N/A | 24.80 | Evidence | |||||
| KIT | ACP1 | ACP1: Low molecular weight phosphotyrosine protein phosphatase | 22.90 | Evidence | |||||
| KIT | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 22.90 | Evidence | |||||
| KIT | SLAMF1 | SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor | 22.40 | Evidence | |||||
| KIT | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 22.30 | Evidence | |||||
| KIT | LATS1 | LATS1, WARTS: Serine/threonine-protein kinase LATS1 | 22.30 | Evidence | |||||
| KIT | ACTN4 | ACTN4: Alpha-actinin-4 | 22.30 | Evidence | |||||
| KIT | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 22.30 | Evidence | |||||
| KIT | ROBO1 | ROBO1, DUTT1: Roundabout homolog 1 precursor | 22.20 | Evidence | |||||
| KIT | IQGAP2 | IQGAP2: Ras GTPase-activating-like protein IQGAP2 | 21.40 | Evidence | |||||
| KIT | SOS1 | SOS1: Son of sevenless homolog 1 | 21.40 | Evidence | |||||
| KIT | CD2AP | CD2AP: CD2-associated protein | 20.50 | Evidence | |||||
| KIT | DOK1 | DOK1: Docking protein 1 | 20.50 | Evidence |
|
||||
| KIT | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 20.00 | Evidence | |||||
| KIT | PRKCQ | PRKCQ, PRKCT: Protein kinase C theta type | 19.70 | Evidence | |||||
| KIT | PLAUR | PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor | 19.10 | Evidence | |||||
| KIT | GAB1 | GAB1: GRB2-associated-binding protein 1 | 18.60 | Evidence | |||||
| KIT | CNN3 | CNN3: Calponin-3 | 18.60 | Evidence | |||||
| KIT | S100B | S100B: Protein S100-B | 18.60 | Evidence | |||||
| KIT | IRS1 | IRS1: Insulin receptor substrate 1 | 18.60 | Evidence | |||||
| KIT | CDC7 | CDC7, CDC7L1: Cell division cycle 7-related protein kinase | 17.10 | Evidence | |||||
| KIT | HLA-DMB | HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec | 17.10 | Evidence | |||||
| KIT | ATP2A2 | ATP2A2, ATP2B: Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 17.10 | Evidence | |||||
| KIT | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 16.60 | Evidence | |||||
| KIT | PLD2 | PLD2: Phospholipase D2 | 16.60 | Evidence | |||||
| KIT | SH3BP5 | N/A | 16.60 | Evidence | |||||
| KIT | DOCK2 | DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 | 16.60 | Evidence | |||||
| KIT | CSH2 | GH1: Somatotropin precursor | 16.40 | Evidence | |||||
| KIT | IRS4 | IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 | 16.40 | Evidence | |||||
| KIT | S100A3 | S100A3, S100E: Protein S100-A3 | 16.40 | Evidence | |||||
| KIT | SPTA1 | SPTA1, SPTA: Spectrin alpha chain, erythrocyte | 16.40 | Evidence | |||||
| KIT | K-ALPHA-1 | TUBA1B: Tubulin alpha-1B chain | 16.20 | Evidence | |||||
| KIT | PIK3CB | PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit | 15.60 | Evidence | |||||
| KIT | CNTN2 | CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor | 15.30 | Evidence | |||||
| KIT | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 15.00 | Evidence | |||||
| KIT | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 15.00 | Evidence | |||||
| KIT | MYL4 | MYL4, MLC1, PRO1957: Myosin light polypeptide 4 | 14.60 | Evidence | |||||
| KIT | DAB1 | DAB1: Disabled homolog 1 | 14.60 | Evidence | |||||
| KIT | H2-ALPHA | TUBA3C, TUBA2, TUBA3D: Tubulin alpha-3C/D chain | 14.10 | Evidence | |||||
| KIT | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 13.50 | Evidence | |||||
| KIT | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 13.2 | Evidence | |||||
| KIT | CD44 | N/A | 12.50 | Evidence | |||||